Status:
COMPLETED
Evaluation of a Management Strategy for Second-degree Fibrinous Burns Integrating a Poly-absorbent Dressing
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Burns Degree Second
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The management of the local treatment of second-degree burns has an influence on the healing time and thus on the quality of the healing process. Fibrin detersion optimizes epidermization and may redu...
Eligibility Criteria
Inclusion
- Adult patient
- 2nd degree burn with : Affected body surface between 0.25 et 10% Fibrinous surface between 9 and 156 centimeter/meter square (major axis between 3 and 16 centimeter, minor axis of 3 centimeter minimum) One or more non-contiguous fibrinous surfaces
- Exudative wet fibrin
- Patient treated with silver sulphadiazine between Day 0 and Day 4
- Patient affiliated to a social security scheme
- Patient who signed a written consent to participate in the study
Exclusion
- Facial burn
- Known diabetic patient
- Patient with severe venous and / or arterial insufficiency (obliterating arteriopathy of the lower limbs stage III and IV)
- Allergy to one of the components of the URGOCLEAN® dressing (polyacrylate fibers, carboxymethylcellulose, paraffin oil, petroleum jelly)
- Person under guardianship or curators
- Patient deprived of liberty
- Patient for whom silver sulphadiazine is contraindicated (last trimester of pregnancy, lactating woman, allergy to sulfa drugs)
- Patient treated with pre-impregnated interfaces (URGOTUL SAG®, IALUSET+® compresses,..) during initial care between Day 0 and Day 4
Key Trial Info
Start Date :
January 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2025
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05347654
Start Date
January 20 2023
End Date
April 29 2025
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Edouard Herriot
Lyon, Rhone, France, 69003